PARIS (Reuters) - Sanofi Pasteur, the vaccines division of Sanofi, said on Wednesday that its dengue vaccine candidate proved effective in a study in fighting the disease, which it described as a threat to almost 3 billion people.
"The results confirm the excellent safety profile of the vaccine candidate," Sanofi said in a statement, referring to a trial carried out in Thailand.
The full data are being reviewed by scientific experts and public health officials, with detailed results to be published later this year, Sanofi said.
Large-scale late-stage Phase III dengue vaccine clinical studies with 31,000 participants are under way in 10 countries in Asia and Latin America, the company added.
(Reporting by James Regan; Editing by Nick Macfie)
Source: http://news.yahoo.com/sanofi-says-dengue-vaccine-effective-trial-052538629--finance.html
andrew lloyd webber obscura grok cirque du freak eric cantor eric cantor pope joan
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.